198 related articles for article (PubMed ID: 32443534)
21. Control of autophagy maturation by acid sphingomyelinase in mouse coronary arterial smooth muscle cells: protective role in atherosclerosis.
Li X; Xu M; Pitzer AL; Xia M; Boini KM; Li PL; Zhang Y
J Mol Med (Berl); 2014 May; 92(5):473-85. PubMed ID: 24463558
[TBL] [Abstract][Full Text] [Related]
22. The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection.
Simonis A; Schubert-Unkmeir A
Biol Chem; 2018 Sep; 399(10):1135-1146. PubMed ID: 29924727
[TBL] [Abstract][Full Text] [Related]
23. Medial calcification in the arterial wall of smooth muscle cell-specific Smpd1 transgenic mice: A ceramide-mediated vasculopathy.
Bhat OM; Yuan X; Cain C; Salloum FN; Li PL
J Cell Mol Med; 2020 Jan; 24(1):539-553. PubMed ID: 31743567
[TBL] [Abstract][Full Text] [Related]
24. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
[TBL] [Abstract][Full Text] [Related]
25. Acid Sphingomyelinase Inhibition Mitigates Histopathological and Behavioral Changes in a Murine Model of Traumatic Brain Injury.
Niziolek GM; Boudreau RM; Baker J; Friend LA; Makley AT; Edwards MJ; Gulbins E; Goodman MD
J Neurotrauma; 2020 Sep; 37(17):1902-1909. PubMed ID: 32138594
[TBL] [Abstract][Full Text] [Related]
26. Use of acid sphingomyelinase for cancer therapy.
Savić R; Schuchman EH
Adv Cancer Res; 2013; 117():91-115. PubMed ID: 23290778
[TBL] [Abstract][Full Text] [Related]
27. Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.
Mühle C; Huttner HB; Walter S; Reichel M; Canneva F; Lewczuk P; Gulbins E; Kornhuber J
PLoS One; 2013; 8(5):e62912. PubMed ID: 23658784
[TBL] [Abstract][Full Text] [Related]
28. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids in inflammatory hypoxia.
Glaser UG; Fandrey J
Biol Chem; 2018 Sep; 399(10):1169-1174. PubMed ID: 29908122
[TBL] [Abstract][Full Text] [Related]
30. Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene.
Boini KM; Xia M; Koka S; Gehr TW; Li PL
Oncotarget; 2016 Apr; 7(14):19031-44. PubMed ID: 26980705
[TBL] [Abstract][Full Text] [Related]
31. Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation.
Gupta S; Natarajan R; Payne SG; Studer EJ; Spiegel S; Dent P; Hylemon PB
J Biol Chem; 2004 Feb; 279(7):5821-8. PubMed ID: 14660582
[TBL] [Abstract][Full Text] [Related]
32. Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies.
Abusukhun M; Winkler MS; Pöhlmann S; Moerer O; Meissner K; Tampe B; Hofmann-Winkler H; Bauer M; Gräler MH; Claus RA
Front Immunol; 2021; 12():784989. PubMed ID: 34987511
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis.
Taniguchi M; Ogiso H; Takeuchi T; Kitatani K; Umehara H; Okazaki T
Cell Death Dis; 2015 Apr; 6(4):e1717. PubMed ID: 25855965
[TBL] [Abstract][Full Text] [Related]
34. Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System.
Becker KA; Halmer R; Davies L; Henry BD; Ziobro-Henry R; Decker Y; Liu Y; Gulbins E; Fassbender K; Walter S
Neurosignals; 2017; 25(1):88-97. PubMed ID: 29131010
[TBL] [Abstract][Full Text] [Related]
35. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.
Chakravarthy H; Navitskaya S; O'Reilly S; Gallimore J; Mize H; Beli E; Wang Q; Kady N; Huang C; Blanchard GJ; Grant MB; Busik JV
Stem Cells; 2016 Apr; 34(4):972-83. PubMed ID: 26676316
[TBL] [Abstract][Full Text] [Related]
36. Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.
Andrews NW
Cell Microbiol; 2019 Nov; 21(11):e13065. PubMed ID: 31155842
[TBL] [Abstract][Full Text] [Related]
37. A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression.
Gulbins E; Walter S; Becker KA; Halmer R; Liu Y; Reichel M; Edwards MJ; Müller CP; Fassbender K; Kornhuber J
J Neurochem; 2015 Jul; 134(2):183-92. PubMed ID: 25925550
[TBL] [Abstract][Full Text] [Related]
38. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy.
Justice MJ; Bronova I; Schweitzer KS; Poirier C; Blum JS; Berdyshev EV; Petrache I
J Lipid Res; 2018 Apr; 59(4):596-606. PubMed ID: 29378782
[TBL] [Abstract][Full Text] [Related]
40. Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma.
Kachler K; Bailer M; Heim L; Schumacher F; Reichel M; Holzinger CD; Trump S; Mittler S; Monti J; Trufa DI; Rieker RJ; Hartmann A; Sirbu H; Kleuser B; Kornhuber J; Finotto S
Cancer Res; 2017 Nov; 77(21):5963-5976. PubMed ID: 28883000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
